Literature DB >> 17765242

A review of postoperative care for obstetric fistulas in Nigeria.

O S Shittu1, O A Ojengbede, L H I Wara.   

Abstract

Nigeria harbors an estimated 40% of all the women affected with obstetric fistulas today, and at the current rate of treatment in this country, it would take about 300 years to treat them if no new fistulas occurred. This situation obviously runs contrary to the ideals of the United Nations Millennium Development Goals and needs to be reversed. We reviewed the literature on fistula treatment in Nigeria to identify strategies and practices that, if adopted, would likely accelerate the pace of fistula repair and improve postoperative fistula care in this country. A comprehensive nationwide survey, a stronger political will and commitment of resources, a systematic postoperative care and follow-up, more fistula centers, and more fistula campaigns are necessary. Technically, the involvement of all surgeons trained in fistula repair and an experience-based postoperative management protocol will relieve the disease burden carried by women living with fistulas in Nigeria.

Entities:  

Mesh:

Year:  2007        PMID: 17765242     DOI: 10.1016/j.ijgo.2007.06.014

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  3 in total

1.  Vaginally inserted herbs causing vesico-vaginal fistula and vaginal stenosis.

Authors:  S E Adaji; S B Bature; O S Shittu
Journal:  Int Urogynecol J       Date:  2012-07-14       Impact factor: 2.894

2.  Vesicovaginal fistula following insertion of a foreign body in the vagina for sexual gratification: could it be catastrophic?

Authors:  Ankur Bansal; Manoj Kumar; Sunny Goel; Ruchir Aeron
Journal:  BMJ Case Rep       Date:  2016-04-12

3.  Uncomplicated midvaginal vesico-vaginal fistula repair in ibadan: a comparison of the abdominal and vaginal routes.

Authors:  I O Morhason-Bello; O A Ojengbede; B O Adedokun; M A Okunlola; A Oladokun
Journal:  Ann Ib Postgrad Med       Date:  2008-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.